The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (156.73) USD. With the latest stock price at 34.66 USD, the upside of Cytokinetics Inc based on DCF is -552.2%.
Based on the latest price of 34.66 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 552.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 10.0% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (555.62) - (95.06) | (156.73) |
| Upside | -1703.1% - -374.3% | -552.2% |